Bausch Health Cos., Inc.
(Toronto Stock Exchange : VRX)

( )
VRX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc. 0.62%25.0814.1%$147.57m
ICLRICON plc -1.55%251.952.8%$141.91m
HZNPHorizon Therapeutics Plc -0.17%86.425.4%$113.85m
BHCBausch Health Cos., Inc. 0.62%25.080.0%$107.94m
CTLTCatalent, Inc. 0.06%102.082.0%$107.71m
JAZZJazz Pharmaceuticals Plc -1.70%136.762.1%$87.59m
SAVACassava Sciences, Inc. -2.89%36.330.0%$85.54m
UTHRUnited Therapeutics Corp. 0.05%200.0613.9%$78.87m
ZGNXZogenix, Inc. -0.08%25.987.5%$77.91m
PRGOPerrigo Co. Plc -2.27%38.846.9%$49.22m
ARGXargenx SE -0.79%279.250.0%$48.42m
PCRXPacira Biosciences, Inc. -0.89%63.439.8%$28.67m
BRBRBellRing Brands, Inc. 0.29%24.330.0%$26.08m
IRWDIronwood Pharmaceuticals, Inc. 0.64%10.999.5%$22.81m
SAGESAGE Therapeutics, Inc. -1.57%38.217.6%$17.91m

Company Profile

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products. The Bausch + Lomb/International segment consists of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Salix segment consists of sales in the U.S. of GI products. The Ortho Dermatologics segment consists of sales in the U.S. of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices. The Diversified Products segment consists of sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, in the U.S. of generic products, in the U.S. of dentistry products. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.